Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors-Reference-Cited by-同舟云学术

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

Published:2020-11-16 Issue:6 Volume:127 Page:884-893
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gelderblom Hans¹^ORCID,Wagner Andrew J.²³^ORCID,Tap William D.⁴⁵,Palmerini Emanuela⁶^ORCID,Wainberg Zev A.⁷,Desai Jayesh⁸,Healey John H.⁴⁵^ORCID,Sande Michiel A. J.¹^ORCID,Bernthal Nicholas M.⁷,Staals Eric L.⁶,Peterfy Charles G.⁹,Frezza Anna Maria¹⁰^ORCID,Hsu Henry H.¹¹,Wang Qiang¹²,Shuster Dale E.¹²,Stacchiotti Silvia¹⁰^ORCID

Affiliation:

1. Leiden University Medical Center Leiden the Netherlands

2. Dana‐Farber Cancer Institute Boston Massachusetts

3. Harvard Medical School Boston Massachusetts

4. Memorial Sloan Kettering Cancer Center New York New York

5. Weill Cornell Medical College New York New York

6. IRCCS Istituto Ortopedico Rizzoli Bologna Italy

7. David Geffen School of Medicine University of California Los Angeles Santa Monica California

8. Peter MacCallum Cancer Centre Melbourne Victoria Australia

9. Spire Sciences, Inc Boca Raton Florida

10. Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

11. Plexxikon Berkeley California